Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

被引：32
|
作者：
Jain, Preetesh [1 ]
Nastoupil, Loretta [1 ]
Westin, Jason [1 ]
Lee, Hun Ju [1 ]
Navsaria, Lucy [1 ]
Steiner, Raphael E. [1 ]
Ahmed, Sairah [1 ]
Moghrabi, Omar [1 ]
Oriabure, Onyeka [1 ]
Chen, Wendy [1 ]
Badillo, Maria [1 ]
Flowers, Christopher R. [1 ]
Wang, Michael L. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 192卷 / 02期
关键词：
Mantle cell lymphoma (MCL); ibrutinib; brexucabtagene autoleucel; BTK inhibitor; venetoclax; chimeric antigen receptor therapy; non-Hodgkin lymphoma;
D O I：
10.1111/bjh.17197
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E38 / E42
页数：5
相关论文
共 50 条
  • [31] Brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma (R/R MCL) in ZUMA-2: Durable responder analysis
    Munoz, Javier
    Reagan, Patrick M.
    Goy, Andre
    Miklos, David B.
    Zheng, Dan
    Fang, Xiang
    Shen, Rhine R.
    Siddiqi, Rubina
    Kloos, Ioana
    Kersten, Marie Jose
    Wang, Michael
    ANNALS OF ONCOLOGY, 2023, 34 : S1380 - S1380
  • [32] Outpatient Administration of Brexucabtagene Autoleucel (brexu-cel) for Acute Lymphoblastic Leukemia (ALL) and Mantle Cell Lymphoma (MCL) Is Safe and Feasible
    Othman, Tamer
    Baird, John H.
    Wang, Yan
    Pak, Stacy
    Aldoss, Ibrahim
    Cai, Ji-Lian
    Danilov, Alexey
    Phillips, Tycel J.
    Agrawal, Uaibhav
    Sandhu, Karamjeet S.
    Mei, Matthew
    Koller, Paul B.
    Palmer, Joycelynne Michelle
    Forman, Stephen J.
    Budde, Lihua E.
    Aribi, Ahmed
    BLOOD, 2024, 144 : 2278 - 2279
  • [33] Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: Real-world experience from the United States lymphoma CAR T consortium.
    Jain, Preetesh
    Wang, Yucai
    Locke, Frederick L.
    Munoz, Javier
    Beitinjaneh, Amer
    Frank, Matthew Joshua
    Dahiya, Saurabh
    Jacobs, Miriam T.
    Hill, Brian T.
    Lekakis, Lazaros J.
    Miklos, David Bernard
    Ghobadi, Armin
    Neelapu, Sattva Swarup
    Lin, Yi
    Wang, Michael
    Jain, Michael D.
    Maurer, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomas
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    FUTURE ONCOLOGY, 2021, 17 (11) : 1269 - 1283
  • [35] Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study
    Stella, Federico
    Chiappella, Annalisa
    Magni, Martina
    Bonifazi, Francesca
    De Philippis, Chiara
    Musso, Maurizio
    Cutini, Ilaria
    Ljevar, Silva
    Barbui, Anna Maria
    Farina, Mirko
    Martino, Massimo
    Massaia, Massimo
    Grillo, Giovanni
    Angelillo, Piera
    Botto, Barbara
    Patriarca, Francesca
    Krampera, Mauro
    Arcaini, Luca
    Tisi, Maria Chiara
    Zinzani, Pierluigi
    Sora, Federica
    Bramanti, Stefania
    Pennisi, Martina
    Carniti, Cristiana
    Corradini, Paolo
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (02) : 644 - 651
  • [36] Outcomes of Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 and ZUMA-18, an Expanded Access Study
    Goy, Andre
    Jacobson, Caron A.
    Flinn, Ian W.
    Hill, Brian T.
    Weng, Wen-Kai
    Mountjoy, Luke
    Olalekan, Oluwole
    Zheng, Dan
    Nunes, Ana
    Zhang, Wangshu
    Shen, Rhine R.
    Kloos, Ioana
    Wang, Michael L.
    BLOOD, 2023, 142
  • [37] Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
    Jain, Preetesh
    Kanagal-Shamanna, Rashmi
    Zhang, Shaojun
    OK, Chi Young
    Navsaria, Lucy
    Nastoupil, Loretta
    Lee, Hun Ju
    Tang, Guilin
    Yin, C. Cameron
    Badillo, Maria
    Nair, Ranjit
    Li, Shaoying
    Patel, Keyur M.
    Flowers, Christopher
    Vega, Francisco
    Wang, Linghua
    Wang, Michael L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E137 - E140
  • [38] COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL, CAR-T) FOR THE TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN GREECE
    Loupas, M. A.
    Theodoratou, D.
    Kourlaba, G.
    VALUE IN HEALTH, 2022, 25 (12) : S112 - S112
  • [39] Confirmation of the good real-life effectiveness of brexucabtagene autoleucel in relapsed/refractory mantle cell lymphomas
    Jules, Higue
    HEMATOLOGIE, 2023, 29 (04): : 224 - 225
  • [40] Postibrutinib outcomes in patients with mantle cell lymphoma
    Martin, Peter
    Maddocks, Kami
    Leonard, John P.
    Ruan, Jia
    Goy, Andre
    Wagner-Johnston, Nina
    Rule, Simon
    Advani, Ranjana
    Iberri, David
    Phillips, Tycel
    Spurgeon, Stephen
    Kozin, Eliana
    Noto, Katherine
    Chen, Zhengming
    Jurczak, Wojciech
    Auer, Rebecca
    Chmielowska, Ewa
    Stilgenbauer, Stephan
    Bloehdorn, Johannes
    Portell, Craig
    Williams, Michael E.
    Dreyling, Martin
    Barr, Paul M.
    Chen-Kiang, Selina
    DiLiberto, Maurizio
    Furman, Richard R.
    Blum, Kristie A.
    BLOOD, 2016, 127 (12) : 1559 - 1563
12345